BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hypothalamus
,
Metabolism of nitric oxide
,
Trichostatin A
,
rs2300478
,
NEUROG3
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cyclins B
Summary
General Info
Curated Studies
Most Correlated Studies
Cyclin D1 in AL Amyloidosis Baseline Plasma Cells
Multiple myeloma cell lines RPMI-8226 and LP1 overexpressing cyclin D1
T cell acute lymphoblastic leukemia MOLT4 cells treated with cyclin-dependent kinase inhibitors
BRD-2-mediated lymphomas
B cell lymphoma VAL and OCI-LY3 cells treated with CDK-9 inhibitor AZ5576 compound
Explore Curated Studies Results
Literature
Most Relevant Literature
Effect of Paracetamol in the Proliferation of Glioblastoma Cell Line: The Role of Apoptosis, COX-2 a…
Two-Step Mechanism of Cyclin B Degradation Initiated by Proteolytic Cleavage with the 26 S Proteasom…
Ordered dephosphorylation initiated by the selective proteolysis of cyclin B drives mitotic exit.
Cyclin B3: Locking female meiosis to await fertilization].
Regulation of the cell cycle under anoxia stress in tail muscle and hepatopancreas of the freshwater…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression
Pre-emptive Cycline Treatment on Cetuximab Induced Skin Toxicity in Colorectal Cancer
Cyclin Dependant Kinase 4/6 (CDK4/6) Inhibitors as a Second Line Treatment in Metastatic Breast Canc…
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Enc…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ